Turner Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Turner Investments’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,970	Closed	-$1.15M	–	583
2014 Q4	$1.15M	Sell	9,970 -2,050	-17%	-$248K	0.14%	250
2014 Q3	$1.88M	Sell	12,020 -15,550	-56%	-$2.25M	0.11%	266
2014 Q2	$3.4M	Sell	27,570 -12,910	-32%	-$1.43M	0.15%	191
2014 Q1	$4.19M	Sell	40,480 -60,434	-60%	-$6.19M	0.11%	228
2013 Q4	$9.08M	Sell	100,914 -35,176	-26%	-$2.81M	0.16%	186
2013 Q3	$9.1M	Sell	136,090 -68,030	-33%	-$4.69M	0.15%	204
2013 Q2	$13.5M	Buy	+204,120	New	+$11.7M	0.18%	190

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Turner Investments's SLXP Position: Q1 2015 in Review

Turner Investments sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 9,970 shares — an estimated $1.15M sold.

Turner Investments first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $13.5M in Q2 2013. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Turner Investments reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Turner Investments sold 9,970 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $1.15M.
Turner Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Turner Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $13.5M in Q2 2013.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Turner Investments's 13F filing for Q1 2015, filed 12 May 2015.